| Literature DB >> 8977168 |
J W Maciaszek1, N A Parada, W W Cruikshank, D M Center, H Kornfeld, G A Viglianti.
Abstract
IL-16 is produced by CD8+ lymphocytes and has been reported to inhibit HIV-1 and SIV replication in infected PBMCs. CD4 serves as a receptor for the secreted form of IL-16, and IL-16 binding to CD4 induces signal transduction, which affects the activation state of the cell. We hypothesized, therefore, that the effect of IL-16 on HIV-1 replication might occur at the level of virus expression. In transient transfection studies with HIV-1 LTR-reporter gene constructs we found that pretreatment of CD4+ lymphoid cells with recombinant IL-16 repressed HIV-1 promoter activity up to 60-fold, preventing both PMA and Tat activation. This effect of IL-16 required sequences contained within the core enhancer, but was not simply due to the down-regulation of transcription factors binding to this element.Entities:
Mesh：
Substances：
Year: 1997 PMID： 8977168
Source DB: PubMed Journal: J Immunol ISSN： 0022-1767 Impact factor: 5.422